Immunecare Biopharmaceuticals (shanghai) Co., Ltd.

This study tests an experimental drug called IMC-003 in people with pulmonary arterial hypertension (PAH), a serious condition where high blood pressure damages the lungs and heart. The trial involves 120 adults who are already on standard treatment. Researchers want to see if th…